Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by elgin1on Nov 01, 2019 12:29am
134 Views
Post# 30295447

RE:RE:RE:11 million shares...

RE:RE:RE:11 million shares...
BioTeck wrote: You may see pennies but I see percentages. Last big sell was at 27 and smaller ones at 26 and 25. The ones sold at 27 were near 40 percent higher than today's close. I've accumulated a decent amount at 19 and will wait before I get anymore. I'll gladly take 40 percent anyday. Heck i'd even take 10. Tell me this. How many percent have you made holding? Or should I say lost?
elgin1 wrote:
BioTeck wrote: Hitting the market in a few weeks. Whatcha guys think? Stuck here till sellers dry up or another pump do PP investors can dump into?



I hear the investors that particpated in pp, are longterm and not traders. So sorry Bioteck, there will be no large selling of 11 millions shares.  Current sp is at close to pp so it will stay here until there is some definitive news on collaboration.

So Bioteck are you fearmonegering, or you going to buy back in to flip for a few pennies?





I own 6 million shares. In it for the long term, plus 1million in warrants for recent pp.  I am an investor not a trader.  Good luck. Ceo owns over 6 million shares personally too so he has skin in the game . Just needs to be derisked with another patient. By the way, 6 moths of c peptide produced since implantation and counting. Novartis good one Bioteck .... 
Bullboard Posts